AURA Takes you to the home page

Aberdeen University Research Archive >
6 - All research >
All research >

Please use this identifier to cite or link to this item:

This item has been viewed 1 times in the last year. View Statistics

Files in This Item:

File Description SizeFormat
Lourenco2008.pdf395.93 kBAdobe PDFView/Open
Title: Alternative approaches to endoscopic ablation for benign enlargement of the prostate : a systematic review of randomised controlled trials
Authors: Lourenco, Tania
Pickard, Robert
Vale, Luke David
Grant, Adrian Maxwell
Fraser, Cynthia Mary
MacLennan, Graeme Stewart
N'Dow, James Michael Olu
Benign Prostatic Enlargement Team
University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences
Keywords: Catheter Ablation
Prostatic Hyperplasia
Transurethral Resection of Prostate
Issue Date: 2008
Publisher: BMJ
Citation: Lourenco, T., Pickard, R., Vale, L., Grant, A., Fraser, C., MacLennan, G., and N'Dow, J. (2008). Alternative approaches to endoscopic ablation for benign enlargement of the prostate : a systematic review of randomised controlled trials. British Medical Journal, 337(7660), pp. 449-457.
Abstract: Objective To compare the effectiveness and risk profile of newer methods for endoscopic ablation of the prostate against the current standard of transurethral resection. Design Systematic review and meta-analysis. Data sources Electronic and paper records in subject area up to March 2006. Review methods We searched for randomised controlled trials of endoscopic ablative interventions that included transurethral resection of prostate as one of the treatment arms. Two reviewers independently extracted data and assessed quality. Meta-analyses of prespecified outcomes were done using fixed and random effects models and reported using relative risk or weighted mean difference. Results We identified 45 randomised controlled trials meeting the inclusion criteria and reporting on 3970 participants. The reports were of moderate to poor quality, with small sample sizes. None of the newer technologies resulted in significantly greater improvement in symptoms than transurethral resection at 12 months, although a trend suggested a better outcome with holmium laser enucleation (random effects weighted mean difference -0.82, 95% confidence interval 1.76 to 0.12) and worse outcome with laser vaporisation (1.49, -0.40 to 3.39). Improvements in secondary measures, such as peak urine flow rate, were consistent with change in symptoms. Blood transfusion rates were higher for transurethral resection than for the newer methods (4.8% v 0.7%) and men undergoing laser vaporisation or diathermy vaporisation were more likely to experience urinary retention (6.7% v 2.3% and 3.6% v 1.1%). Hospital stay was up to one day shorter for the newer technologies. Conclusions Although men undergoing more modern methods of removing benign prostatic enlargement have similar outcomes to standard transurethral resection of prostate along with fewer requirements for blood transfusion and shorter hospital stay, the quality of current evidence is poor. The lack of any clearly more effective procedure suggests that transurethral resection should remain the standard approach.
ISSN: 0007-1447
Appears in Collections:Applied Health Sciences research
All research

SFX Query

Items in AURA are protected by copyright, with all rights reserved, unless otherwise indicated.


The University of Aberdeen
King's College
AB24 3FX
Tel: +44 (0)1224-272000